DISITAMAB VEDOTIN

Clinical trials for DISITAMAB VEDOTIN explained in plain language.

Never miss a new study

Get alerted when new DISITAMAB VEDOTIN trials appear

Sign up with your email to follow new studies for DISITAMAB VEDOTIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Triple attack on tough bile duct cancer

Disease control Not yet recruiting

This study is testing a new three-drug combination for people with advanced bile duct cancer that has a specific marker called HER2. The goal is to see if the combination can shrink tumors and control the disease. About 65 participants will receive the treatment, and researchers …

Matched conditions: DISITAMAB VEDOTIN

Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

DISITAMAB VEDOTIN

Get alerted when new DISITAMAB VEDOTIN trials appear

Triple attack on tough bile duct cancer